Vista Latin America signs major enterprise software

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
81
Vista Latin America signs major enterprise software agreement with Cinépolis, the world’s fourth largest cinema chain

AUCKLAND, New Zealand and MORELIA, Mexico, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Vista Latin America, a subsidiary of Vista Entertainment Solutions Ltd, the world’s leading cinema management software provider to the global cinema exhibition industry, is delighted to announce the signing of a five-year Enterprise Software Agreement with Mexico-based Cinépolis, the world’s fourth largest cinema chain.

Vista Entertainment Solutions Ltd ‘(Vista Cinema’) is a Vista Group International company (NZX:VGL) (ASX:VGL).

The Enterprise Agreement will cover all 625 of the cinema sites currently owned by Cinépolis throughout the world (5,170 screens), as well as future cinema sites. 

Vista Cinema CEO Kimbal Riley says the deal is a natural extension of the relationship Vista has had with Cinépolis since 2009.

“This Enterprise Agreement with our long-time customer Cinépolis is the latest development in our strategy to secure longer-term Vista partnerships. Through the term of the agreement, it will enable Cinépolis to implement at agreed fees all products in the full suite of Vista Cinema software. Cinépolis has also committed to implementing Vista Cinema in Brazil, the world’s fifth largest cinema market. The deal also reinforces Vista’s recent announcement to incorporate our long-term Latin American business partner into Vista Group.” 

Co-CEO of Vista Latin America, Gustavo Ortega, says: “This agreement marks another step forward in our relationship with Cinépolis, enabling us to grow together as we both continue on a global journey of expansion.”

"The signing of this agreement highlights Vista’s ability to work in partnership with Cinépolis, one of the world’s leading exhibitors and one that is continually using innovative technology to benefit their customers,” says co-CEO of Vista Latin America, Armando Mejias.

“This deal sets out a path to continue our solid operation worldwide, which will involve bringing Brazil on board, and with the support of our joint Cinépolis-Vista partnership, will offer sustainable growth,” says Cinépolis’s Global IT Director, Gabriel Morales Becker.

About Vista Latin America Vista Latin America was created in 2017 following an acquisition agreement between Vista Entertainment Solutions Ltd and its long-term Mexican business partner Senda Dirección Tecnológica, SA de CV.  Senda was founded in Mexico City in 2002 by Armando Mejias and Gustavo Ortega, who continue to lead the new company. Prior to the formation of Vista Latin America, since 2003 Senda distributed Vista Cinema software in Mexico and in 14 other countries in the region.

About Vista Entertainment Solutions Vista Entertainment Solutions Ltd (Vista Cinema) is the world leader in cinema management software solutions with installations in more than 80 countries around the world and an estimated 38% global market share in the Large Cinema Circuit market. The Vista Cinema software product line comprises multiple modules, integrated and scalable, suited to cinema exhibitors operating 20+ screens and 100s of cinemas. Vista Cinema is head-quartered in Auckland, New Zealand and has subsidiaries incorporated in Los Angeles, London, Shanghai, Beijing, Cape Town and Mexico City.  Website: www.vista.co Twitter:   @VistaCinema LinkedIn: www.linkedin.com/company/vista-entertainment-solutions

About Vista Group International: Vista Group International (Vista Group) is a public company, listed on both the New Zealand and Australian stock exchanges (NZX:VGL) (ASX:VGL). The Group provides software and additional technology solutions across the global film industry. Cinema management software is provided by Vista Cinema, the core business of the Group. Movio (authority in moviegoer data analytics), Veezi (cloud-based SaaS software for the Independent Cinema Market), movieXchange (connecting the movie industry to simplify the promotion and sale of movie tickets), Maccs (film distribution software), Numero (box office reporting software for film distributors and cinemas), Cinema Intelligence (business intelligence solutions), Powster (creative studio and marketing platform for movie studios) and Flicks (moviegoer ‘go to’ portal for movie information) provide an innovative range of complementary products across additional film industry sectors, from production and distribution, to cinema exhibition through to the moviegoer experience. Vista Group has offices located in New Zealand (Auckland HQ), Sydney, Los Angeles, London, Shanghai, Beijing, Cape Town, Mexico City, the Netherlands and Romania. Website: www.vistagroup.co   LinkedIn: www.linkedin.com/company/vista-group-limited

About Cin é polis: Cinépolis is the world’s 4th largest movie theater circuit, operating more than 5,170 screens in 14 countries and serving more than 317 million patrons annually. Cinépolis operates under four different brands that span the ultra-premium to the extreme value segments. It was the first cinema exhibitor in the world to pioneer the concept of premium and luxury movie theaters via its Cinépolis VIP brand. Cinépolis aspires to provide its patrons the best overall experience in filmed entertainment and employs a global workforce of 40,874 people to support its mission. Founded in 1971, Cinépolis headquarters is located in Morelia, Mexico.

Press Contacts:  
   
Vista Group International/Auckland, NZ                                      MBC/ Los Angeles
Christine Fenby Maggie Begley (for Vista Group International)
+64 21 727 006 +1 310-390-0101
christine.fenby@vista.co maggie@mbcprinc.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 1

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 99

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Analyzing RTX: Trends in Short Interest and Market Sentiment

Updated Category News Views 176

Understanding RTX's Recent Market Movements RTX Corp has seen a notable shift in its market dynamics recently. The company's short interest, defined as the number of shares sold short but not yet covered, has decreased by 7.63% since the last reporting period. Currently, there are approximately 16.18 million shares sold short, equating to 1.21% of all shares available for...

Continue Reading
Celebrate Christmas Spirit with Personalized PrayerSongs

Updated Category News Views 156

Celebrate the Joy of Christmas with PrayerSong Bring Love Into Your Home with a PrayerSong for Your Family and Friends When the holiday season arrives, the focus shifts beyond material gifts. Instead, it’s about nurturing connections filled with love, faith, and meaningful moments. This Christmas, PrayerSong provides families with a unique opportunity to honor loved...

Continue Reading
Understanding the Short Selling Landscape of Analog Devices

Updated Category News Views 153

Analyzing Short Interest for Analog Devices As investors navigate the ever-changing stock market, understanding short interest can provide valuable insights into market sentiment regarding Analog Devices (NYSE: ADI). Recently, it was reported that Analog Devices has seen a notable increase of 4.11% in its short percent of float. Currently, there are approximately 7.52...

Continue Reading
Future of Clinical Trials: Exploring Market Growth to USD 85.37 Billion

Updated Category News Views 71

Understanding Clinical Trials and Their Importance Clinical trials serve as a fundamental pillar in advancing medical knowledge and enhancing patient care. These trials encompass a detailed and thorough process involving participant recruitment, intervention administration, data collection, and result analysis. The outcomes produced from clinical trials play a crucial...

Continue Reading